Healthcare -
Biotechnology - NASDAQ - US
$ 24.05
-4.37 %
$ 2.99 B
Market Cap
-15.03
P/E
APLS - TOTAL CURRENT LIABILITIES
Total Current Liabilities APLS - Apellis Pharmaceuticals, Inc.
248 M
LAST VALUE
37.04%
2 YEAR CAGR
70.82%
5 YEAR CAGR
80.43%
10 YEAR CAGR